SEC Form 4 insider trading filings tracked in real time from EDGAR

Mehta Vimal — CEO and President

Insider trading activity for Mehta Vimal sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: CEO and President
  • Company: BioXcel Therapeutics, Inc.
  • Total insider trades: 2
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: May 7, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
May 1, 2026 Mehta Vimal BTAI BioXcel Therapeutics, Inc. OTHER 18,000 N/A
May 1, 2026 Mehta Vimal BTAI BioXcel Therapeutics, Inc. OTHER 18,000 N/A

← All executives · Full trades feed